Annual report pursuant to Section 13 and 15(d)

Net Income (Loss) per Common Share - Anti-dilutive Securities (Details)

v3.22.4
Net Income (Loss) per Common Share - Anti-dilutive Securities (Details) - shares
3 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2021
Sep. 30, 2021
Dec. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities (in shares) 14,196,994 25,281,983 29,237,144
Warrants to purchase shares of common stock      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities (in shares) 14,166,666 14,166,666 14,166,644
Options to purchase shares of common stock      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities (in shares) 0 8,978,185 7,603,864
Restricted shares of common stock      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities (in shares) 30,328 2,137,132 7,466,636